Search
Insight Molecular Diagnostics Ord Shs
IMDXAdd to Watchlist
6.410USD
-0.010-0.16%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
206.98MMarket Cap
LossP/E TTM
More Details of Company
Insight Molecular Diagnostics Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Insight Molecular Diagnostics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
152.16K
+36.15%
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
39.51K
+88.59%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
38.37K
+90.86%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
36.56K
+95.72%
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Andrea S. James
Ms. Andrea S. James
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
152.16K
+36.15%
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
39.51K
+88.59%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
38.37K
+90.86%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
36.56K
+95.72%
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Pharma Services
4.01M
99.00%
kitted products
40.55K
1.00%
By RegionUSD
Name
Revenue
Proportion
United States Pharma services
4.01M
99.00%
Outside of the United States - Pharma Services
40.55K
1.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharma Services
4.01M
99.00%
kitted products
40.55K
1.00%
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
39.75%
Smith (Patrick W)
10.09%
AWM Investment Company, Inc.
8.72%
Bio Rad Laboratories Inc
8.56%
Pura Vida Investments, LLC
2.93%
Other
29.95%
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
39.75%
Smith (Patrick W)
10.09%
AWM Investment Company, Inc.
8.72%
Bio Rad Laboratories Inc
8.56%
Pura Vida Investments, LLC
2.93%
Other
29.95%
Shareholder Types
Shareholders
Proportion
Hedge Fund
43.33%
Individual Investor
11.63%
Investment Advisor/Hedge Fund
10.50%
Corporation
8.56%
Investment Advisor
3.06%
Research Firm
0.21%
Pension Fund
0.08%
Other
22.62%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
44
16.28M
56.94%
--
2026Q1
71
18.24M
55.57%
+1.77M
2025Q4
59
16.33M
56.98%
-21.02K
2025Q3
63
16.26M
56.74%
-114.67K
2025Q2
76
16.21M
8.76%
+317.02K
2025Q1
86
16.10M
56.30%
+2.27M
2024Q4
89
8.43M
48.30%
-193.34K
2024Q3
99
7.19M
53.72%
-268.68K
2024Q2
118
7.51M
59.43%
+222.34K
2024Q1
152
4.82M
59.90%
+9.71K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Broadwood Capital, Inc.
12.08M
37.56%
+671.83K
+5.89%
Feb 10, 2026
Smith (Patrick W)
3.26M
10.13%
--
--
May 12, 2025
AWM Investment Company, Inc.
2.81M
8.75%
-8.30K
-0.29%
Dec 31, 2025
Bio Rad Laboratories Inc
2.76M
8.59%
+1.25M
+82.94%
Feb 10, 2025
Pura Vida Investments, LLC
947.13K
2.94%
--
--
Dec 31, 2025
FNY Investment Advisers LLC
40.58K
0.13%
-12.49K
-23.54%
Dec 31, 2025
Geode Capital Management, L.L.C.
230.97K
0.72%
+32.52K
+16.39%
Dec 31, 2025
James (Andrea S.)
206.06K
0.64%
+17.00K
+8.99%
Mar 26, 2026
Arno (Andrew)
152.16K
0.47%
+55.00K
+56.61%
Jul 01, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
DFA Dimensional US Small Cap Value ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jul 24, 2023
Merger
20→1
Date
Ex-dividend Date
Type
Ratio
Jul 24, 2023
Merger
20→1
